Sheng Tang Selected Research

Sheng Tang Research Topics

Disease

10	Neoplasms (Cancer) 04/2022 - 10/2013
4	Infections 01/2021 - 09/2017
2	Epilepsy (Aura) 10/2020 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2020 - 03/2010
2	Dehydration (Water Stress) 12/2019 - 07/2019
2	Critical Illness (Critically Ill) 01/2019 - 04/2014
2	Human Influenza (Influenza) 01/2019 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 11/2014
2	Breast Neoplasms (Breast Cancer) 11/2014 - 10/2013
1	Thrombosis (Thrombus) 05/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022
1	Rheumatoid Arthritis 01/2022
1	CDKL5 deficiency disorder 10/2021
1	Pain (Aches) 10/2021
1	Pathologic Constriction (Stenosis) 10/2021
1	COVID-19 10/2021
1	Cytokine Release Syndrome 10/2021
1	Spinal Stenosis (Stenosis, Spinal) 10/2021
1	Hemorrhage 01/2021
1	Inflammation (Inflammations) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2020
1	Brain Neoplasms (Brain Tumor) 10/2020
1	Spasm (Spasms) 10/2020
1	Insulin Resistance 09/2020
1	Gram-Negative Bacterial Infections 06/2020
1	Pneumonia (Pneumonitis) 06/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 12/2018
1	Glioblastoma (Glioblastoma Multiforme) 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Carcinoma (Carcinomatosis) 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017
1	Myocarditis (Carditis) 01/2017
1	Neurodevelopmental Disorders 01/2017
1	Coxsackievirus Infections 01/2017
1	Intellectual Disability (Idiocy) 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Glioma (Gliomas) 06/2014

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 10/2021 - 11/2012
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2021 - 01/2017
2	BerberineIBA 01/2021 - 01/2016
2	Immune Checkpoint InhibitorsIBA 11/2020 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2016
2	MatrinesIBA 09/2020 - 11/2014
2	EstersIBA 01/2019 - 11/2014
2	sophoridinic acidIBA 04/2016 - 11/2014
2	Antineoplastic Agents (Antineoplastics)IBA 11/2014 - 10/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 10/2013
2	sophoridinolIBA 11/2014 - 06/2014
1	cabozantinibIBA 04/2022
1	indoleIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CytokinesIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	olmutinibIBA 05/2021
1	Therapeutic UsesIBA 01/2021
1	N 30IBA 01/2021
1	Complement System Proteins (Complement)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020
1	Blood Glucose (Blood Sugar)IBA 09/2020
1	Monobactams (Monobactam Antibiotics)IBA 06/2020
1	SulfonamidesIBA 12/2019
1	Metal-Organic FrameworksIBA 12/2019
1	PorphyrinsIBA 12/2019
1	Petroleum (Crude Oil)IBA 07/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2019
1	cytisineIBA 01/2019
1	Amantadine (Aman)FDA LinkGeneric 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2018
1	butaneIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	benzocycloheptapyridineIBA 01/2018
1	Hydroxyl RadicalIBA 09/2017
1	ProdrugsIBA 09/2017
1	IMB-6GIBA 04/2016
1	Pentylenetetrazole (Metrazol)IBA 01/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 04/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2013

Therapy/Procedure

2	Punctures 01/2021 - 03/2010
2	Therapeutics 11/2020 - 04/2016
1	Central Venous Catheters 05/2022
1	Decompression 10/2021
1	Laminectomy 10/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Radiotherapy 10/2020
1	Nanospheres 12/2019
1	Nutritional Support (Artificial Feeding) 01/2019
1	Intravenous Injections 01/2019
1	Enteral Nutrition (Feeding, Tube) 01/2019
1	Adjuvant Chemotherapy 12/2017
1	Chemoradiotherapy 12/2017